lunes, 20 de febrero de 2023

Rare Disease patient advocates call for a bold, joined-up approach in the evolution of the Orphan Medicinal Products Regulation - EURORDIS

Rare Disease patient advocates call for a bold, joined-up approach in the evolution of the Orphan Medicinal Products Regulation - EURORDIS

No hay comentarios: